Search

everythinglearnresearchcommunity

for

Search:↓

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Balding men have harder scalps.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

The laser treatment improved hair appearance and was safe and well-received by patients.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Male hair loss is caused by inactive hair follicle stem cells.

Finasteride reduces caspase levels, helping hair growth in AGA patients.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Defective nuclear transport may cause gene expression changes in Progeria.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

New regenerative therapies show promise for treating hair loss.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

A gene called HDAC9 might be a new factor in male-pattern baldness.

TGF-β1 and 2 may play a role in hair loss in AGA.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Apremilast may help treat hair loss in alopecia areata.

Angio PRP speeds up skin wound healing and reduces inflammation.

Valproic Acid helps regrow hair in mice and activates a hair growth marker in human cells.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.